Chronic exposure to elevated levels of manganese (Mn) has been linked to a Parkinsonian-like movement disorder, resulting from dysfunction of the extrapyramidal motor system within the basal ganglia. However, the exact cellular and molecular mechanisms of Mn-induced neurotoxicity remain elusive. In this study, we treated C57BL/6J mice with 30 mg/kg Mn via oral gavage for 30 days. Interestingly, in nigral tissues of Mn-exposed mice, we found a significant downregulation of the truncated isoform of p73 protein at the N-terminus (DNp73). To further determine the functional role of Mn-induced p73 downregulation in Mn neurotoxicity, we examined the interrelationship between the effect of Mn on p73 gene expression and apoptotic cell death in an N27 dopaminergic neuronal model. Consistent with our animal study, 300 mM Mn treatment significantly suppressed p73 mRNA expression in N27 dopaminergic cells. We further determined that protein levels of the DNp73 isoform was also reduced in Mn-treated N27 cells and primary striatal cultures. Furthermore, overexpression of DNp73 conferred modest cellular protection against Mn-induced neurotoxicity. Taken together, our results demonstrate that Mn exposure downregulates p73 gene expression resulting in enhanced susceptibility to apoptotic cell death. Thus, further characterization of the cellular mechanism underlying p73 gene downregulation will improve our understanding of the molecular underpinnings of Mn neurotoxicity.
Introduction
Neurodegenerative diseases are becoming more prevalent due to aging populations and exposure to an increasing array of environmental toxicants such as pesticides, neurotoxic metals and industrial byproducts (Caudle et al., 2012; Goldman, 2014; Kanthasamy et al., 2012; White et al., 2015) . The transition metal manganese (Mn) is an essential trace nutrient that not only serves as a co-factor for a variety of enzymes including superoxide dismutase 2 and glutamine synthetase, but is also important for various normal physiological functions including bone formation, fat and carbohydrate metabolism, as well as the regulation of blood sugar, cellular energy, the immune system and calcium absorption (Aschner et al., 2009) . Mn has been used widely in various industries for more than two centuries. The primary routes of Mn exposure are inhalation in occupational settings and dietary consumption in general. Airborne Mn particles from various chemicals including methylcyclopentadienyl manganese tricarbonyl (MMT) and fungicide are another important source of public exposure (Bowman et al., 2011; Caudle et al., 2012) . Mn overexposure causes a neurodegenerative disorder known as manganism. Many clinical symptoms of manganism are also seen in Parkinson's disease (PD) patients, including gait dysfunction, postural instability, bradykinesia, rigidity and a mask-like face expression (Guilarte, 2011) . Pathologically, both manganism and PD show dopaminergic neuronal cell death in the substantia nigra (SN) and striatum (STR). But unlike PD, manganism is unresponsive to L-dopa therapy and develops psychological abnormalities in its early phase.
The p73 gene (also known as Trp73) belongs to the p53 tumor suppressor gene family, and like other family members, codes for multiple mRNA transcripts (Rosenbluth and Pietenpol, 2008) . Besides playing an important role in regulating differentiation, cell death, and neural stem cells, p73 is also implicated in neurodegenerative diseases such as Alzheimer's disease (Engelmann et al., 2015; Killick et al., 2011; Yang et al., 2002) . The p73 gene has 15 exons and two different transcription start sites. The C-terminal domain of p73 is alternatively spliced generating a variety of isoforms. Transcripts from the upstream promoter generate transactivation domain-containing isoforms of p73 (TAp73), while transcripts from the second promoter produce the N-terminal transactivation domain-truncated isoform subfamily (DNp73). Similar to the p53 tumor suppressor, TAp73 induces apoptosis and serves as a tumor suppressor. Interestingly, DNp73 inhibits cellular apoptosis by directly inhibiting TAp73 activity (Nakagawa et al., 2002) . The p53 family members, including p73, share highly similar protein architectures and cellular targets, but they have different upstream signals (Rosenbluth and Pietenpol, 2008) .
Manganese-induced neurotoxicity has been studied extensively, and several key players, such as protein kinase C delta (PKCd) (Latchoumycandane et al., 2005) , SLC30A10 (Chen et al., 2015; Leyva-Illades et al., 2014) , ATM-p53 (Tidball et al., 2015) , and others (Horning et al., 2015) have been identified. Previous evidence also indicates that manganese-induced neurotoxicity involves activation of caspase-3 signaling (Anantharam et al., 2004; Latchoumycandane et al., 2005) . Moreover, caspase-3 has been shown to cleave p73 (Sayan et al., 2008) . Mn exposure induces mitochondria-mediated apoptosis in neurons, which is partially facilitated by p53 (Wan et al., 2014) , and DNp73 antagonizes the functional p53 by regulating the expression of anti-apoptotic molecules such as Bcl-xL and Mcl-1 (Basu and Haldar, 1998; Grob et al., 2001; Huttinger-Kirchhof et al., 2006; Melino et al., 2002 (Grand Island, NY) and Rockland (Gilbertsville, PA), respectively. RPMI 1640, fetal bovine serum, L-glutamine, penicillin, and streptomycin were purchased from Life Technologies. We purchased the tetrapeptide caspase-3 inhibitor zDEVDfmk from ApexBio (Houston, TX).
Animal studies
Six-to eight-week-old male C57BL/6J mice were housed at RT under a 12-h light cycle with water and food provided ad libitum.
MnCl 2 Á4H 2 O (10 or 30 mg/kg) was orally administered once daily for 30 days. Animals were cared for in accordance with Institutional Animal Care and Use committee guidelines. After the treatment period, nigral tissues were collected for measuring the expression of proteins of interest.
Cell cultures
A rat-derived dopaminergic neuronal cell line, N27, was kindly gifted from Dr. Kedar N. Prasad (University of Colorado Health Sciences Center, Denver, CO). N27 cells were maintained in RPMI 1640 media supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 50 units of penicillin, and 50 mg/ml of streptomycin in a humidified incubator with 5% CO 2 at 37 C as described previously .
Primary striatal cultures and treatment
Primary striatal neuronal cultures were prepared from the ganglionic eminences of gestational 14-to 15-day-old mouse embryos as previously described (Martin et al., 2011) . Briefly, after extracting the embryonic brain, the embryonic cerebral cortex was folded away to expose ganglionic eminences followed by dissection of the STR, which were then washed in Dulbecco's modified eagle media (DMEM) and dissociated via trypsinization. Dissociated cells were seeded into poly-D-lysine-coated plates and maintained in Neurobasal medium supplemented with B-27 supplements, 500 mM L-glutamine, 100 IU/ml penicillin, and 100 mg/ ml streptomycin in a humidified incubator with 5% CO 2 at 37 C. Four-to six-day-old primary striatal neuronal cells were exposed to various concentrations of Mn (100-500 mM) for 24 h and then subjected to Western blot analysis.
Plasmid constructs
The expression plasmid for the human p73 alpha isoform (HAp73alpha-pcDNA3) was obtained from Addgene (ID 22102) as described (Jost et al., 1997) . To generate the expression vector for the N-terminal transactivation domain-truncated p73 isoform, the appropriate cDNA fragment was PCR-generated from HA-p73al-pha-pcDNA3 using a forward primer, 5 0 -CAGATTACGCTAGCTGCTG-TACGTCGGTGACCCCGCACGGCACCTCGCCACGGCCCAGTT-CAATCTGCTGAGCAGCACC-3 0 , and the SP6 reverse primer. The restriction enzymes of NheI and XhoI were used to generate the 5 0 overhang cleavage site, which was used for the ligation reaction with pcDNA3 vector. The resulting clone for DNp73 was confirmed by sequencing.
Transfections
N27 cells were transfected with DNp73 DNA construct through electroporation. The Amaxa Nucleofector instrument was used according to the manufacturer's protocol. Five million cells were transfected with 10 mg of plasmids using the A-23 program.
Transfected cells were seeded in either T-75 flasks or 96-well plates as desired for 24 h before treatment (Zhang et al., 2007b) .
Cell viability assays
Colorimetric MTS assay was performed to measure mitochondrial activity as an indirect measure of cell viability using the Cell Titer 96 Aqueous One Solution Proliferation Assay kit from Promega as described previously (Jin et al., 2014) . Briefly, cells were seeded in 96-well plates before exposure to Mn. At the end of treatment, 20% MTS reagent was added to each well. The MTS tetrazolium compound is bio-reduced in living cells to its colored formazan products. After incubating for up to one hour, absorbance at 490 nm was measured using a SpectraMax spectrophotometric microplate reader (Molecular Devices).
Quantitative RT-PCR
After treatment, total RNA was extracted from cells using the Absolutely RNA Miniprep kit and converted to cDNA using the High Capacity cDNA Synthesis kit (Life Technologies). SYBR Green quantitative PCR was performed according to the manufacturer's protocol. Forward primer (5 0 -ACTGCAAGTCCCGTAAGCAG-3 0 ) and reverse primer (5 0 -CATGAGCGACTTCCCTTCAG-3 0 ) were used for detecting p73 mRNA. Validated primers for 18S rRNA (Qiagen, #PPR57734E) were used as the housekeeping gene controls. The threshold cycle (C t ) was calculated from the instrument software, and fold change in gene expression was calculated using the DDC t method.
Behavioral measurements
Spontaneous exploratory movements of mice were measured using a computer-controlled open-field apparatus (VersaMax animal activity monitor, model RXYZCM-16, Accuscan, Columbus, OH) as described previously (Zhang et al., 2007a) . The transparent activity chamber was 40 Â 40 Â 30.5 cm and was covered with a transparent ventilated lid. Data were collected and analyzed by a VersaMax analyzer (model CDA-8, AccuScan). Following a 2-min adaptation period, each mouse was given 10 min to explore the open-field monitor while horizontal and vertical movements were recorded automatically via an array of infra-red beams.
Western blotting
Cells were lysed in lysis buffer (1% Triton X-100, 1 mM EDTA, 100 mM NaCl, 1 mM EGTA, 1 mM NaF, 20 mM Na 4 P 2 O 7 , 2 mM Na 3 VO 4 , 10% glycerol, 0.1% SDS, 0.5% deoxycholate, 50 mM Tris-Cl, pH 7.4). Brain homogenates were prepared as described previously . Western blotting was performed as described previously (Jin et al., 2014) . Briefly, the samples containing equal amounts of proteins were fractionated through a 10-15% SDS-PAGE gel and transferred onto a nitrocellulose membrane. Primary antibodies against specific proteins were incubated with the membrane. After thoroughly rinsing in PBS supplemented with 0.1% Tween-20, the membrane was incubated with Alexa Fluor 680 goat anti-mouse, Alexa Fluor 680 donkey anti-goat, or IRDye 800 donkey anti-rabbit secondary antibodies.
For the loading control, b-actin antibody was used. Immunoblot imaging was performed with an Odyssey Infrared Imaging system (LI-COR, Lincoln, NE, USA). ImageJ software (National Institutes of Health, Bethesda MD, USA) was used to quantify Western blot bands.
Statistical analysis
Data were analyzed using Prism 4.0 (GraphPad Software, San Diego, CA). Tukey's multiple comparison test was used after ANOVA for comparing differences between multiple groups. Paired Student's t-test was used when two groups were being compared. Differences were considered statistically significant for p-values < 0.05. All data were determined from at least two biologically independent experiments, each done in triplicate (3 samples from the same culture, flask etc.). Data are represented as the mean AE S.E.M. (n = 6-9).
Results

Manganese exposure suppresses DNp73 expression in mouse substantia nigra
To investigate whether Mn exposure has any effect on the expression of p73 proteins in vivo, C57BL mice were orally treated with 30 mg/kg/day of Mn for 30 days and then their nigral tissues were subjected to biochemical analysis. To perform isoformspecific gene expression analyses of p73 gene products, we used vehicle control animals were administered de-ionized water. After treatments, locomotor activity was measured using an automated VersaMax locomotor activity monitor. Representative activity maps of open-field movements of Mn-treated mice and control mice revealed Mn-induced locomotor deficits (A). Mn treatment also reduced total distance traveled (cm) during a 10-min test of locomotor activity (B). Western blot assays were performed on substantia nigral lysates to measure the expression of DNp73 (C).
Densitometric analysis was also performed (D). Data are expressed as percent of control and represented as mean AE S.E.M. from four animals per group. Asterisk (*, p < 0.05) indicates significant differences between treatment and control groups. two specific antibodies directed against full-length and truncated p73 proteins, respectively. Interestingly, expression of DNp73 in Mn-treated mice was reduced by more than 50% when compared to control mice (Fig. 1C,D) . Full-length p73 protein expression was not changed (data not shown). Behavioral performance testing also confirmed that 30 mg/kg Mn treatment caused significant motor deficits (Fig. 1A,B) . These findings in an animal model indicate that Mn exposure induced downregulation of DNp73 expression. We examined p73 mRNA expression by qRT-PCR (A). Data are expressed as percent of control and represented as mean AE S.E.M. from six independent experiments. Asterisk (***, p < 0.001) indicates significant differences between treatment and control groups. N27 cells were exposed to 300 mM of Mn for 6-24 h. Expression of DNp73 protein was measured by Western blot assays (B). Densitometric analysis was performed (C). Data are expressed as percent of control and represented as mean AE S.E.M. from three independent experiments. Asterisks (*, p < 0.05) indicate significant differences between treatment and control groups. Fig. 3 . Mn downregulates DNp73 in primary striatal neurons. Primary striatal neurons were exposed to 100-500 mM of Mn for 24 h in reduced sera. Expression of DNp73 protein was measured by Western blot assays (A). Densitometric analysis was performed (B). Data are expressed as percent of control and represented as mean AE S.E.
M. from three independent experiments. Asterisks (*, p < 0.05; **, p < 0.01) indicate significant differences between treatment and control groups.
Manganese exposure downregulates DNp73 expression in N27 dopaminergic cells and mouse primary striatal cultures
We further characterized the Mn-induced downregulation of p73 expression and its functional consequence in the in vitro N27 dopaminergic neuronal cell system. N27 cells were exposed to 300 mM Mn for 6-24 h, and quantitative RT-PCR analysis was performed for p73 gene expression after 24 h ( Fig. 2A) . We found $60% reduction of p73 gene expression relative to control cells. Furthermore, Western blot analysis revealed that
DNp73 expression was downregulated upon exposure to 300 mM in a time-dependent manner with $60% reduction relative to control cells 24 h after treatment (Fig. 2B,C) DNp73, we showed that exposing mouse primary striatal cultures for 24 h to increasing concentrations of Mn (100-500 mM)
concentration-dependently repressed
DNp73 expression (Fig. 3A,B) .
Downregulation of DNp73 is not dependent on manganeseinduced caspase-3 activation
To investigate the possibility that activated caspase-3 contributes to the reduction of DNp73 protein levels by inducing proteolytic cleavage of DNp73, we used the cell-permeable, irreversible caspase-3 inhibitor zDEVD-fmk to selectively inhibit caspase-3 activation (Anantharam et al., 2004) . N27 dopaminergic cells were pre-exposed to either 20 or 50 mM of zDEVD-fmk for 1 h before exposure to 300 mM of Mn. Pre-treatment of N27 cells with zDEVD-fmk did not alter DNp73 expression levels (data not shown). Interestingly, the Mn-induced downregulation of DNp73 was unaffected by the presence of zDEVD-fmk (Fig. 4A,   B ), indicating that caspase-dependent proteolytic cleavage is unlikely to be involved in the suppression of DNp73. (Fig. 5A,B) and Mcl-1 (Fig. 5C,D (Fig. 6A,B) , and then exposed the cells to increasing concentrations of Mn for 24 h. The overexpression of
DNp73 modestly inhibited the Mn-induced loss of cell viability during exposure to 100 and 200 mM Mn as indicated via MTS assay, but was unable to overcome the toxic effect of 300 mM Mn Fig. 4 . Caspase-3 inhibition does not alter the downregulation of DNp73 during Mn-induced neurotoxicity. N27 dopaminergic cells were pre-treated with either 20 or 50 mM of the caspase-3 inhibitor zDEVD-fmk before exposure to 300 mM of Mn for 24 h in reduced sera. Expression of DNp73 protein was measured by Western blot assays (A).
Densitometric analysis was performed (B). Data are expressed as percent of control and represented as mean AE S.E.M. from three independent experiments. Asterisks (*, p < 0.05; **, p < 0.01) indicate significant differences between treatment and control groups. (Fig. 6C) . Taken together, these data suggest that DNp73 suppression sensitizes dopaminergic cells to Mn-induced cell death and that the suppression of the anti-apoptotic DNp73 protein may contribute to Mn-induced neurotoxicity.
Discussion
In the present study, we provide evidence that the tumor suppressor gene p73 is highly susceptible to Mn-induced neurotoxicity in the nigrostriatal system. To our knowledge, this is the first evidence that Mn exerts its neurotoxic effects by suppressing expression of the anti-apoptotic DNp73 protein, thereby providing novel mechanistic insights into the molecular events underlying Mn neurotoxicity.
Although several molecules have been identified as key mediators of Mn neurotoxicity leading to apoptosis, including the pro-apoptotic kinase PKCd (Latchoumycandane et al., 2005; Zhang et al., 2007b) , caspase-12, caspase-3 (Chun et al., 2001; Wang et al., 2015) , and p53 Yang et al., 2007) , the exact molecular and cellular mechanisms of how chronic Mn exposure induces dopaminergic neuronal cell death have not been fully characterized. The p73 protein has been shown to participate in a wide variety of cellular events, including cell death, selfrenewal and cell cycle regulation (Di et al., 2013; Engelmann et al., 2015; Fatt et al., 2014; Killick et al., 2011) . The p73 protein has several isoforms characterized by alternative transcription at the N-terminus and alternative splicing at the C-terminus. Interestingly, TAp73 isoforms having the N-terminal transactivation domain induce apoptosis, whereas DNp73 isoforms lacking the transactivation domain antagonize TAp73 functions, thereby favoring cell survival. We examined p73 protein expression in an in vivo animal model exposed to 30 mg/kg for 30 days. Mn exposure reduced total distance of movement compared to controls, showing Mn exposure induced SN degeneration (Fig. 1A,B) . Importantly, we provide in vivo evidence that expression of DNp73 (Fig. 1C,D) was downregulated in Mn-treated mice relative to controls, suggesting that DNp73 plays an important role in Mn-induced neurotoxicity. Since Mn exposure downregulates DNp73 in an isoform-specific manner, this gene has potential value in the development of a biomarker for Mn exposure.
Characterizing the isoform function of p73 may provide a better understanding of how Mn overexposure induces dopaminergic neuronal cell death. Our quantitative RT-PCR results revealed that Mn exposure downregulates p73 gene expression in N27 dopaminergic neuronal cells (Fig. 2A) . The concentration of 300 mM Mn in N27 cells is lower than the 0.5-1 mM Mn used to induce toxic effects in mouse hippocampal neurons or human neuroblastoma cells (Tamm et al., 2008; Yoon et al., 2011) . Furthermore, depending upon the dose, duration and route of exposure, Mn concentrations can reach up to 350 mM in certain brain regions (Horning et al., 2015; Ingersoll et al., 1999; Roels et al., 1997) . Adult mice exposed to 30 mg/kg for 8 weeks showed symptoms of Mn-induced toxicological effects (Moreno et al., 2009) . Thus, Mn concentrations used in our study are within the relevant toxicological range and are consistently used in neurotoxicological studies by our group and by many leading laboratories (Aschner et al., 2007; Harischandra et al., 2015; Stredrick et al., 2004) . The downregulation induced by 300 mM Mn occurred over 12 h in N27 cells, indicating that DNp73 downregulation occurred Fig. 5 . Expression of the downstream effectors of the p73 signaling pathway is also downregulated in Mn-induced neurotoxicity. N27 dopaminergic cells were exposed to 100-500 mM of Mn for 24 h in reduced sera. Expression of Bcl-xL (A) and the longer isoform of Mcl-1 (C) was measured by Western blot assays. Densitometric analysis was performed (B and D). Data are expressed as percent of control and represented as mean AE S.E.M. from three independent experiments for Bcl-xL and four independent experiments for Mcl-1, respectively. Asterisks (*, p < 0.05; ***, p < 0.001) indicate significant differences between treatment and control groups.
during early stages of the cell death process. Our results from primary striatal neuronal cells exposed to different concentrations of Mn revealed that Mn downregulated the expression of DNp73 in a concentration-dependent manner. Caspase-3 was shown to cleave full-length TAp73 under apoptotic conditions, releasing a 45-kDa fragment (Sayan et al., 2008) . Our inhibition of caspase-3 failed to recover DNp73 suppression. Moreover, we did not observe a $40-kDa cleaved product of DNp73. These data indicate that DNp73 suppression involves caspase-3-independent mechanisms. Interestingly, p73 undergoes proteasomal degradation (Asher et al., 2005; Bernassola et al., 2004; Jung et al., 2011) , but further research is needed to reveal whether p73 degradation plays a role in Mn-induced DNp73 repression.
In addition to caspase-mediated proteolysis and proteasomal degradation, transcriptional suppression of the p73 gene is another important mechanism to negatively alter p73 activity (Chen et al., 2001; Putzer et al., 2003) . Runt-related transcription factor 2 and the transcription factor repressor ZEB bind to p73 promoter and transcriptionally suppress p73 expression (Bui et al., 2009; Fontemaggi et al., 2001; Ozaki et al., 2014) . Additionally, epigenetic mechanisms, such as DNA hypermethylation, have been suggested to account for DNp73 transcriptional repression (Lai et al., 2014) .
Mn exposure induces DNA damage via oxidative stress (Oikawa et al., 2006; Stephenson et al., 2013) and upregulates p53 (Wan et al., 2014) . Furthermore, genotoxic stress has been shown to selectively degrade DNp73 via the antizyme AZ1 (Dulloo et al., 2010) . It is plausible that DNA damage induced by Mn exposure via oxidative stress may reduce DNp73 and antagonize TAp73 as well as p53. Therefore, altered mRNA stability and protein stability may also contribute to Mn-induced DNp73 downregulation. Future studies will focus on providing further evidence and mechanisms for Mn-induced transcriptional repression of the p73 gene.
Bax is one of the transcriptional targets of the p73 gene (Graupner et al., 2011; Melino et al., 2004) . Consistent with a previous report (Gonzalez et al., 2008) , our results indicate that Mn exposure upregulated Bax (data not shown). Bcl-xL and Mcl-1 were reported to suppress activation of Bax and Bak, respectively (Finucane et al., 1999; Sedlak et al., 1995) . Downregulation of Bcl-xL and Mcl-1 during Mn exposure (Fig. 5) indicates that downregulation of DNp73 may play a role in fine-tuning the activity of p73. When we overexpressed DNp73 in N27 dopaminergic neurons, we observed a 2-fold increase in DNp73 expression compared to empty vector-transfected N27 cells. After 24 h posttransfection, DNp73 overexpression modestly inhibited an Mninduced loss of viable cells (Fig. 6C) at low concentrations of 100 and 200 mM Mn, but not against the 300 mM concentration.
Considering that chronic exposure to low doses of Mn leads to neurodegeneration in the long-term, the modest protective effects against low Mn concentrations offered by DNp73 overexpression may have important implications for Mn neurotoxicity.
In conclusion, our results demonstrate that
DNp73 downregulation significantly contributed to Mn neurotoxicity. These observations provide new insights into the mechanisms underlying Mn-induced dopaminergic neurotoxicity. Further characterization of the molecular mechanisms underlying DNp73 downregulation will provide a better understanding of Mninduced neurotoxicity.
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